Eveready Industries India Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Eveready Industries India Limited has announced the schedule of its Q1FY27 Earnings Conference Call, to be held on August 10, 2026, at 4:30 pm IST.
BSE & NSE corporate filings with AI summaries
Eveready Industries India Limited
Eveready Industries India Limited has announced the schedule of its Q1FY27 Earnings Conference Call, to be held on August 10, 2026, at 4:30 pm IST.
TVS Motor Company Limited
TVS Motor Company Limited has informed the Exchange about a copy of newspaper publication regarding a special window for transfer and dematerialisation of physical securities.
CORONA Remedies Limited
CORONA Remedies Limited has announced its unaudited financial results for Q1FY27, reporting a revenue growth of 21.9% and a PAT growth of 30.1% Y-o-Y, driven by robust brand building and operational excellence.
Genesys International Corporation Limited
Genesys International Corporation Limited has announced a rights issue of 2,50,74,226 equity shares at Rs. 50 per share, with a record date of August 06, 2026, and a rights entitlement ratio of 3:5.
Sumit Woods Limited
Sumit Woods Limited has informed the Exchange regarding Notice of Postal Ballot to seek shareholders' consent for related party transactions, remuneration of CFO and MD, and other resolutions.
Ajooni Biotech Limited
Ajooni Biotech Limited has informed the Exchange about an increase in its authorized capital from Rs. 35,00,00,000 to Rs. 70,00,00,000, with the number of equity shares increasing from 17,50,00,000 to 35,00,00,000, following approval at its 16th Annual General Meeting.
Ajooni Biotech Limited
Ajooni Biotech Limited has informed the Exchange about the issuance of 90,00,000 equity shares on a preferential basis, approved by the members at the 16th Annual General Meeting.
Ajooni Biotech Limited
Ajooni Biotech Limited has informed the Exchange about the re-appointment of Mr. Gursimran Singh as Director who retires by rotation, as approved by the 16th Annual General Meeting of the company.
Ajooni Biotech Limited
Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, where the members have approved the increase in Authorised Share Capital and Amendment of Capital Clause of the Memorandum of Association.
Dhampur Sugar Mills Limited
Dhampur Sugar Mills Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, to the National Stock Exchange of India Ltd. and the BSE Limited. The results include the standalone and consolidated financial statements for the quarter.
Atul Limited
Atul Limited has held its 49th Annual General Meeting on July 31, 2026, and has announced the voting results for three resolutions. All three resolutions were passed with high voting percentages, with the first two resolutions receiving 99.99% and 99.99% votes in favor, and the third resolution receiving 96.04% votes in favor.
TTK Prestige Limited
TTK Prestige Limited has informed the Exchange about the Earnings Call Transcript held on July 28, 2026, which is available on their website.
Neueon Corporation Limited
The Board of Directors of Neueon Corporation Limited has approved a rights issue to eligible equity shareholders to raise up to Rs. 15,079 lakhs, and has also approved the shifting of the company's registered office to a new location, subject to shareholder approval.
BGR Energy Systems Limited
BGR Energy Systems Limited has published un-audited standalone and consolidated financial results for the quarter ended 30th June 2026 in newspapers.
SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited has informed the Exchange about change in Management. The Board of Directors have approved the re-appointment of Mr. Ramesh Babu Potluri as a Chairman and Managing Director of the Company for a term of 5 consecutive years. The company has also approved to give loan to SMS Peptides Private Limited, Subsidiary Company, up to an aggregate amount not exceeding Rs. 50 Crores.
Archean Chemical Industries Limited
Archean Chemical Industries Limited has informed the Exchange about the publication of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
CORONA Remedies Limited
CORONA Remedies Limited has submitted its financial results for Q1FY27, showing a revenue growth of 21.9% and a PAT growth of 30.1% Y-o-Y. The company has also announced the inauguration of its EU-GMP approved Female Hormone Manufacturing Facility and the integration of the Wokadine brand.
Star Health and Allied Insurance Company Limited
Star Health and Allied Insurance Company Limited has informed the Exchange about the schedule of a meet with Analysts/Investors dated August 05, 2026. The meeting will be held in Hong Kong and will feature presentations by the company.
LIC Housing Finance Limited
LIC Housing Finance Limited has informed the Exchange about Presentation and Link of Recording of Analysts/Institutional Investor Meet/Con. Call Updates.
TCI Express Limited
TCI Express Limited has informed the Exchange about the schedule of an analysts' and investors' conference call to discuss the un-audited financial results for the first quarter ended June 30, 2026.